It is the belief of Carbiotix that activity within the gut microbiome is more important than the presence
of specific bacteria species. As such, the company is focused on engineering microbiome modulators (proprietary
second-generation soluble fibers, isolated bacterial strains and novel delivery mechanisms) to
restore and optimize gut microbiome metabolic processes and thereby obtain a desired therapeutic effect
through an improved metabolic profile.
Understanding the functional characteristics related to the activity of the human
microbiome in health and disease together with a strong team in molecular biology, ecology and biocatalysis puts Carbiotix
among the front runners in the development of new microbiome-based therapeutics.